Xenon Pharmaceuticals, Inc. (XENE)
55.66
+0.09
(+0.16%)
USD |
NASDAQ |
Mar 26, 15:58
Xenon Pharmaceuticals Free Cash Flow : -280.51M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aurinia Pharmaceuticals, Inc. | 135.69M |
| Oncolytics Biotech, Inc. | -18.79M |
| Edesa Biotech, Inc. | -8.004M |
| Lexaria Bioscience Corp. | -8.775M |
| ProMIS Neurosciences, Inc. | -27.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -79.06M |
| Cash from Investing (Quarterly) | 60.79M |
| Cash from Financing (Quarterly) | 113.73M |
| Free Cash Flow Per Share (Quarterly) | -0.9906 |
| Free Cash Flow to Equity (Quarterly) | -78.99M |
| Free Cash Flow to Firm (Quarterly) | -79.37M |
| Free Cash Flow Yield | -6.36% |